when truvada and other similar hiv medications came onto the u.s. market in 2001, gilead led patients to believe these antiviral medications were safe to take. and more importantly, taking truvada was a smart way to help protect yourself from hiv. what patients weren’t told was that truvada could cause an increased risk of bone density problems and kidney failure.  a 2012 study conducted by doctors at the university of california – san francisco ucsf found that the risk of chronic kidney disease increased by 33% each year that a patient took truvada.  in response, a gilead executive told the wall street journal that the study “overstates some of the risks.”  if you were you prescribed truvada, atripla, complera, stibild or viread when other equally effective medications without potentially dangerous side effects could have been taken, it is not okay.
truvada